Patents by Inventor Christof Hauck

Christof Hauck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compound for use against pathogenic and species and
    Patent number: 11596626
    Abstract: The present invention relates to a compound, which can be used in the prevention and treatment of infections with pathogenic Neisseria species, in particular N. gonorrhoeae and N. meningitidis (the gonococcus and the meningococcus, respectively), and other pathogenic bacteria (e.g. Haemophilus species or Moraxella catarrhalis), and which can be used for disinfecting a substrate from said bacteria. Moreover, the present invention relates to a corresponding pharmaceutical composition comprising said compound.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: March 7, 2023
    Assignee: Universität Konstanz
    Inventors: Thomas Böttcher, David Szamosvari, Christof Hauck, Tamara Schuhmacher, Petra Muenzner-Voight
  • Compound for Use Against Pathogenic Neisseria and Haemophilus Species and Moraxella Catarrhalis
    Publication number: 20210169869
    Abstract: The present invention relates to a compound, which can be used in the prevention and treatment of infections with pathogenic Neisseria species, in particular N. gonorrhoeae and N. meningitidis (the gonococcus and the meningococcus, respectively), and other pathogenic bacteria (e.g. Haemophilus species or Moraxella catarrhalis), and which can be used for disinfecting a substrate from said bacteria. Moreover, the present invention relates to a corresponding pharmaceutical composition comprising said compound.
    Type: Application
    Filed: December 14, 2018
    Publication date: June 10, 2021
    Inventors: Thomas BÖTTCHER, David SZAMOSVARI, Christof HAUCK, Tamara SCHUHMACHER, Petra MUENZNER-VOIGHT
  • Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis
    Publication number: 20070009481
    Abstract: The present invention is related to the use of an adeno-associated virus, whereby the adeno-associated virus comprises a) FRNK or a derivative thereof, or b) a nucleic acid encoding FRNK or a derivative thereof, or of a nucleic acid coding for an adeno-associated virus, whereby the nucleic acid comprises a nucleic acid encoding FRNK, for the coating of an implant, preferably for the coating of a stent and/or for the coating of a catheter.
    Type: Application
    Filed: July 19, 2004
    Publication date: January 11, 2007
    Inventors: Martin Laser, Christof Hauck, Jorg Strotmann